Fox Chase Cancer Center News

Stephen M. Sykes, PhD
January 7, 2019

Stephen M. Sykes Receives American Cancer Society Grant for Acute Myeloid Leukemia Research

With this grant, the Sykes lab will seek to uncover molecular targets that can serve as a basis for developing novel acute myeloid leukemia (AML) therapies.

December 13, 2018

Fox Chase Cancer Center Pancreatic Cancer Researcher Receives American Cancer Society Research Grant

The American Cancer Society’s newly formed Pennsylvania/New Jersey Pay-If Research Council has funded Jaye Gardiner, PhD, to  continue her efforts to understand the signaling from cell-cell interactions in the pancreatic tumor microenvironment.

Jonathan Chernoff, MD, PhD
December 11, 2018

Jonathan Chernoff Receives Melanoma Research Foundation Grant to Support RAC1 Mutant Melanoma Work

PHILADELPHIA (December 11, 2018) — Jonathan Chernoff, MD, PhD, chief scientific officer and Stanley P. Reimann Chair in Oncology Research at Fox Chase Cancer Center, has received a grant from the Melanoma Research Foundation to support his research on RAC1 mutant melanoma. 

Denise C. Connolly, PhD
December 3, 2018

Breaking Down Barriers

Dr. Denise Connolly has led the way in changing how ovarian cancer is understood. Her lab pioneered the first transgenic mouse model that develops spontaneous ovarian carcinomas, making it easier for scientists everywhere to study ovarian cancers. 

November 30, 2018

Rishi Jain Joins the Department of Hematology/Oncology at Fox Chase Cancer Center

PHILADELPHIA (November 30, 2018) – Fox Chase Cancer Center is pleased to announce the hiring of Rishi Jain, MD, MS, DABOM, as an assistant professor in the Gastrointestinal Medical Oncology Program.

Warren D. Kruger, PhD
November 28, 2018

Warren Kruger Receives NIH Grant to Further Study Treatment of Rare Genetic Disorder Classical Homocystinuria

PHILADELPHIA (November 28, 2018) – Warren D. Kruger, PhD,  has received a grant from the National Institutes of Health to study whether proteasome inhibitors (Pls) and proteostasis modulators are effective in restoring function to treating cystathionine beta synthase (CBS) deficiency, also known as classical homocystinuria.

Y. Lynn Wang, MD, PhD, FCAP
November 27, 2018

Y. Lynn Wang Joins the Department of Pathology at Fox Chase Cancer Center

PHILADELPHIA (November 26, 2018) – Y. Lynn Wang, MD, PhD, FCAP, is a board-certified molecular pathologist who specializes in the development and interpretation of molecular and genomic clinical assays including next-gen sequencing assays. As part of her transition, the Wang Lab was relocated to Fox Chase from the University of Chicago.

Paul Engstrom
November 27, 2018

A Pioneer of Prevention

Looking back on the remarkable career of medical oncologist Paul F. Engstrom. who retires after nearly 50 years of service at Fox Chase Cancer Center


Connect with Fox Chase